A team of researchers from the Montreal Heart Institute believe they have found an effective weapon against COVID-19: Colchicine, an oral tablet already known and used for other diseases.
The ColCorona study involved 4,159 patients whose diagnosis of COVID-19 had been confirmed by a nasopharyngeal test (PCR).
Analysis of the study found that colchicine resulted in reductions in hospitalizations by 25 per cent, the need for mechanical ventilation by 50 per cent, and deaths by 44 per cent.
